AI Mood Market: Stock Dashboard

Company: Anavex Life Sciences Corporation

Sector: Healthcare

Industry: Biotechnology

Country: USA

Exchange: NASD

Index: RUT

P/E: -

EPS (ttm): -0.57

Insider Own: 3.35%

Shs Outstand: 85.41M

Perf Week: -15.51%

Market Cap: 823.72M

Forward P/E: 6.76

EPS next Y: 1.42

Insider Trans: 0.00%

Shs Float: 83.02M

Perf Month: -12.66%

Enterprise Value: 722.56M

PEG: -

EPS next Q: -0.14

Inst Own: 38.04%

Short Float: 29.89%

Perf Quarter: 15.26%

Income: -48.17M

P/S: -

EPS this Y: -6.06%

Inst Trans: 2.44%

Short Ratio: 23.66

Perf Half Y: 12.56%

Sales: 0.00M

P/B: 9.01

EPS next Y Percentage: 357.28%

ROA: -39.47%

Short Interest: 24.81M

Perf YTD: -10.71%

Book/sh: 1.06

P/C: 8.14

EPS next 5Y: -

ROE: -43.63%

52W High: 14.44 -33.59%

Perf Year: 55.30%

Cash/sh: 1.18

P/FCF: -

EPS past 3/5Y: 1.74% 0.85%

ROIC: -52.96%

52W Low: 4.93 94.52%

Perf 3Y: -12.74%

Dividend Est.: -

EV/EBITDA: -

Sales past 3/5Y: - -

Gross Margin: -

Volatility W: 6.92%

Volatility M: 7.25%

Perf 5Y: 144.33%

Dividend TTM: -

EV/Sales: -

EPS Y/Y TTM: -13.05%

Oper. Margin: -

ATR (14): 0.69

Perf 10Y: 99.79%

Dividend Ex-Date: -

Quick Ratio: 8.93

Sales Y/Y TTM: -

Profit Margin: -

RSI (14): 36.75

Recom: 1.00

Dividend Gr. 3/5Y: - -

Current Ratio: 8.93

EPS Q/Q: -7.34%

SMA20: -14.13%

Beta: 0.83

Target Price: 34.33

Payout: -

Debt/Eq: 0.00

Sales Q/Q: -

SMA50: -6.90%

Rel Volume: 0.75

Prev Close: 9.94

Employees: 42

LT Debt/Eq: 0.00

Earnings: Aug 12 BMO

SMA200: 3.49%

Avg Volume: 1.05M

Price: 9.59

IPO: Aug 02, 2006

Option/Short: Yes / Yes

EPS/Sales Surpr.: -12.44% -

Trades:

Volume: 788,882

Change: -3.57%

AI Market Mood: Stock Dashboard

AVXL

Fundamental

Technical:

Latest News:

Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference neutral

ANVS AVXL LGVN